Cognitive, Emotional and Behavioural Impairments in Patients After Sars-Cov2 Infection

Cognitive and Neuropsychiatric Features of COVID-19 Patients After Hospital Dismission: an Italian Sample.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05143320

Enrollment

Registered

2021-12-03

Start date

2021-01-08

Completion date

2021-10-29

Last updated

2021-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Sars-CoV-2 Infection

Keywords

Covid-19, Cognition, Teleneuropsychology, Memory, Executive Functions

Brief summary

Recent studies suggest cognitive, emotional and behavioural impairments occur in patients after SARS-CoV-2 infection. Problems with memory, attention, information processing and executive functions are particularly prevalent in these patients, probably due to hypothesised sensitivity of the hippocampus to the virus. Cognitive impairment is also present in patients with no neurological, neuropsychological and neuropsychiatric history. Therefore, the aim of the present study is to describe neuropsychological and neuropsychiatric features in patients recovered from moderate to severe forms of Covid-19 some weeks after hospital dismission.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

30 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* Positive PCR from nasopharyngeal swab * No ICU admission

Exclusion criteria

* Diagnosis of neurologic or psychiatric disorders; * Previous cognitive impairment; * Other medical conditions negatively affecting the cognitive status.

Design outcomes

Primary

Measure	Time frame	Description
Cognitive and neuropsychiatirc symptoms in Covid-19 patients	About 20 days after hospital dismission	Prevalence of neuropsychological and neuropsychiatric impairment in patients after hospitalization in patients with Sars-Cov2 infection.

Countries

Italy

Outcome results